Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 2, 2001, Pages 28-34

  Dossenbach, M R K ^a   Kratky, P ^a   Schneidman, M ^a   Grundy, S L ^a   Metcalfe, S ^a   Tollefson, G D ^a   Belmaker, R H ^a  

^a Lilly Area Medical Center Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MOOD; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; HUMANS; MALE; PIRENZEPINE; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0035124105     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. New antipsychotics
2. Risperidone in the treatment of chronic schizophrenic patients: An international multicentre double-blind parallel-group comparative study versus haloperidol
3. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
4. Risperidone: A review of its pharmacology and therapeutic potential in the treatment of schizophrenia
5. The pharmacology of olanzapine and other new antipsychotic agents
6. Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial
7. Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
8. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
9. A blinded, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesias with olanzapine or haloperidol
10. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations
11. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
12. The Brief Psychiatric Rating Scale
13. The Extrapyramidal SYmptom Rating Scale